<--- Back to Details
First PageDocument Content
Autoimmune diseases / Colitis / Abdominal pain / Ulcerative colitis / Inflammatory bowel disease / Colonoscopy / Infliximab / Mesalazine / Colorectal cancer / Medicine / Health / Gastroenterology
Autoimmune diseases
Colitis
Abdominal pain
Ulcerative colitis
Inflammatory bowel disease
Colonoscopy
Infliximab
Mesalazine
Colorectal cancer
Medicine
Health
Gastroenterology

An upper limit for macromolecular crowding effects

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 1,36 MB

Share Document on Facebook

Similar Documents

Medicine / Immunosuppressants / Immunology / Clinical medicine / Monoclonal antibodies / Cytokines / Therapeutic antibodies / Autoimmune diseases / Infliximab / Anakinra / Adalimumab / Interferon

EAP Reimbursement Criteria for Frequently Requested Drugs

DocID: 1rhhE - View Document

Medicine / Immunology / Clinical medicine / Health care / Immunosuppressants / Biotechnology / Monoclonal antibodies / Immune system / Immunogenicity / Autoimmunity / Infliximab / Arthritis

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qY7G - View Document

Medicine / Clinical medicine / Health care / Immunology / Immunosuppressants / Monoclonal antibodies / Biotechnology / Immune system / Infliximab / TNF inhibitor / Rheumatology / Biopharmaceutical

JUNE 2015 TABLE OF CONTENTS INTRODUCTION

DocID: 1qDC6 - View Document

Medicine / Clinical medicine / Immunology / RTT / Autoimmune diseases / Immunosuppressants / Rheumatology / Arthritis / Disease-modifying antirheumatic drug / Infliximab / Methotrexate / Psoriatic arthritis

Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8Toll Free on PEI) Programmes provinciaux de médicaments

DocID: 1qAvE - View Document

Medicine / Clinical medicine / Immunology / Immunosuppressants / Monoclonal antibodies / RTT / Immune system / Infliximab / TNF inhibitor / Immunogenicity / Arthritis / Adalimumab

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qs3R - View Document